Skip to content

What is Vaccinium sprengelii? — PlantSage

0Vaccinium sprengelii·What is5 answers
0Section · 00

What is Vaccinium sprengelii

— Short, snippet-friendly answers to the most-asked questions about Vaccinium sprengelii (Vaccinium sprengelii). For the full profile with citations, open the main page.

What is Vaccinium sprengelii?

Vaccinium sprengelii, commonly known as the Assam blueberry or Himalayan blueberry, is a deciduous shrub native to the eastern regions of Asia, including Assam, Cambodia, China South-Central, East Himalaya, Laos, Myanmar, and Thailand. Vaccinium sprengelii (Latin: Vaccinium sprengelii) is a medicinal plant catalogued in PlantSage.

What is Vaccinium sprengelii used for?

Vaccinium sprengelii is most often used to support digestion and immune support. Each claim is rated by evidence strength - see the full profile for citations.

Is Vaccinium sprengelii safe?

Vaccinium sprengelii is generally considered safe when used at traditional doses. Always consult a clinician before using any herbal preparation — especially during pregnancy, breastfeeding, while on medication, or for children.

Where does Vaccinium sprengelii grow?

Vaccinium sprengelii is a member native to ASS, CBD, CHC, EHM, LAO, and MYA. Vaccinium sprengelii thrives in full to partial sun and prefers moist, well-drained soil that is light (sandy) or medium in texture.

Can I grow Vaccinium sprengelii at home?

Vaccinium sprengelii grows best in USDA zone 6-9, full sun, partial sun/shade light, and moist water. Detailed sowing, propagation, and care notes are on the full profile.

Full profile Safety by audience →Preparation forms →Edible plants index →Browse catalogue →
❦❦❦❦
Endpaper · archive updates

Primește digest-ul săptămânal

Un email curat pe săptămână — profile noi de plante, note sezoniere de cultivare, adăugiri în arhiva de remedii. Gratuit, fără tracking, dezabonare oricând.

Newsletter returning soon.
We are rebuilding the update list around a lightweight editorial workflow. New dispatches will resume after the next content review cycle.